Literature DB >> 26175634

Target-specific oral anticoagulants: should we switch from warfarin?

Payam Safavi-Naeini, Mohammad Saeed.   

Abstract

Entities:  

Keywords:  Administration, oral; anticoagulants/administration & dosage/adverse effects/classification/pharmacokinetics; atrial fibrillation/drug therapy; blood coagulation/drug effects; dose-response relationship, drug; stroke/prevention & control; target-specific oral anticoagulants; warfarin/therapeutic use

Mesh：

Substances：

Year:  2015        PMID： 26175634      PMCID： PMC4473615          DOI： 10.14503/THIJ-15-5065

Source DB:  PubMed          Journal:  Tex Heart Inst J        ISSN： 0730-2347


× No keyword cloud information.
  11 in total

Review 1.  Duration of treatment with vitamin K antagonists in symptomatic venous thromboembolism.

Authors:  B A Hutten; M H Prins
Journal:  Cochrane Database Syst Rev       Date:  2006-01-25

2.  2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society.

Authors:  Craig T January; L Samuel Wann; Joseph S Alpert; Hugh Calkins; Joaquin E Cigarroa; Joseph C Cleveland; Jamie B Conti; Patrick T Ellinor; Michael D Ezekowitz; Michael E Field; Katherine T Murray; Ralph L Sacco; William G Stevenson; Patrick J Tchou; Cynthia M Tracy; Clyde W Yancy
Journal:  Circulation       Date:  2014-03-28       Impact factor: 29.690

Review 3.  Comparisons between novel oral anticoagulants and vitamin K antagonists in patients with CKD.

Authors:  Ziv Harel; Michelle Sholzberg; Prakesh S Shah; Katerina Pavenski; Shai Harel; Ron Wald; Chaim M Bell; Jeffrey Perl
Journal:  J Am Soc Nephrol       Date:  2014-01-02       Impact factor: 10.121

4.  New oral anticoagulants for atrial fibrillation: are they worth the risk?

Authors:  Hira Shafeeq; Tran H Tran
Journal:  P T       Date:  2014-01

5.  European Heart Rhythm Association Practical Guide on the use of new oral anticoagulants in patients with non-valvular atrial fibrillation.

Authors:  Hein Heidbuchel; Peter Verhamme; Marco Alings; Matthias Antz; Werner Hacke; Jonas Oldgren; Peter Sinnaeve; A John Camm; Paulus Kirchhof
Journal:  Europace       Date:  2013-05       Impact factor: 5.214

Review 6.  Assessment of anticoagulation intensity and management of bleeding with old and new oral anticoagulants.

Authors:  Aaron Liew; John W Eikelboom; Martin O'Donnell; Robert G Hart
Journal:  Can J Cardiol       Date:  2013-07       Impact factor: 5.223

7.  Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials.

Authors:  Christian T Ruff; Robert P Giugliano; Eugene Braunwald; Elaine B Hoffman; Naveen Deenadayalu; Michael D Ezekowitz; A John Camm; Jeffrey I Weitz; Basil S Lewis; Alexander Parkhomenko; Takeshi Yamashita; Elliott M Antman
Journal:  Lancet       Date:  2013-12-04       Impact factor: 79.321

Review 8.  Efficacy and safety of the novel oral anticoagulants in atrial fibrillation: a systematic review and meta-analysis of the literature.

Authors:  Francesco Dentali; Nicoletta Riva; Mark Crowther; Alexander G G Turpie; Gregory Y H Lip; Walter Ageno
Journal:  Circulation       Date:  2012-10-15       Impact factor: 29.690

9.  Pharmacology and management of the vitamin K antagonists: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).

Authors:  Jack Ansell; Jack Hirsh; Elaine Hylek; Alan Jacobson; Mark Crowther; Gualtiero Palareti
Journal:  Chest       Date:  2008-06       Impact factor: 9.410

Review 10.  Transitioning to and from the novel oral anticoagulants: a management strategy for clinicians.

Authors:  Elsayed Abo-Salem; Richard Becker
Journal:  J Thromb Thrombolysis       Date:  2014-04       Impact factor: 2.300
View more
  3 in total

1.  Time in Therapeutic Range of Oral Vitamin K Antagonists in Hospitalized Elderly Patients.

Authors:  Laurent Lafarge; Fouzi Khayi; Anis Bel-Kamel; Nicolas Charhon; Laura Sarfati; Benoit Falquet; Michel Ducher; Laurent Bourguignon
Journal:  Drugs Aging       Date:  2018-06       Impact factor: 3.923

2.  What's New in Anticoagulation.

Authors:  Joanna Esther Molina Razavi; Payam Safavi-Naeini; Mehdi Razavi
Journal:  Tex Heart Inst J       Date:  2016-10-01

3.  Predictors of new oral anticoagulant drug initiation as opposed to warfarin in elderly adults: a retrospective observational study in Southern Italy.

Authors:  Francesca Guerriero; Valentina Orlando; Valeria Marina Monetti; Francesca Maria Colaccio; Maurizio Sessa; Cristina Scavone; Annalisa Capuano; Enrica Menditto
Journal:  Ther Clin Risk Manag       Date:  2018-10-08       Impact factor: 2.423
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.